DiscoverACRO's Good Clinical Podcast
ACRO's Good Clinical Podcast
Claim Ownership

ACRO's Good Clinical Podcast

Author: ACRO

Subscribed: 13Played: 84
Share

Description

ACRO’s Good Clinical Podcast dives into topics vital to driving innovation in clinical research, from AI and other cutting-edge technology to regulatory topics that impact clinical trials around the world. ACRO's Sophia McLeod is joined by leaders from across the drug development industry to discuss the latest trends and what direction the industry must head to continue improving trials for patients 

37 Episodes
Reverse
As precision medicine advances and oncology therapies become increasingly complex, are clinical trials evolving fast enough to keep pace and are we making them too burdensome for the patients they are designed to serve?In this episode of ACRO’s Good Clinical Podcast, host Sophia McLeod is joined by Angela Fix and David Cohan to explore how the industry can rethink oncology clinical trial design, improve patient access, and translate scientific advances into more effective and efficient research.The conversation examines the role of artificial intelligence in patient identification, protocol design, and data analysis; the potential of decentralized and hybrid approaches to bring trials closer to patients; and the importance of simplifying trial requirements while maintaining patient safety and data quality. The discussion also highlights persistent operational challenges, including biomarker-driven enrollment and the manufacturing and supply chain demands of increasingly complex therapies.Looking ahead, the guests consider how AI, broader care networks, and emerging treatments such as tumor vaccines could reshape oncology clinical trials over the next five years.
As clinical trials become increasingly digital and interconnected, cybersecurity is critical to protecting data integrity, maintaining trial continuity, and safeguarding patient safety. In this episode of ACRO’s Good Clinical Podcast, Sophia McLeod is joined by cybersecurity leaders Nelly Nauman (Parexel), Mick Ryan (ICON), and Charley Newberry (Syneos) to explore the evolving cyber threat landscape facing clinical research.In this episode, they discuss emerging cybersecurity risks, including AI, ransomware, third-party vulnerabilities, and decentralized trials. Speakers shared their experience and strategies for strengthening cyber resilience, protecting data integrity, and fostering industry collaboration to safeguard clinical research.They also shared perspectives on emerging security challenges and why cybersecurity, data trust, and patient safety must be built into clinical trial design from day one.
Collaboration is at the core of connecting the clinical research ecosystem without adding to the technology burden for sites. The ongoing partnership between Advarra and ICON offers a practical example of what this can look like.In Good Clinical Podcast Season 5, Episode 3, Mike Eckrote (Advarra) and Travis Caudill (ICON) discuss how their collaboration is helping move toward an ecosystem where organizations and sites can continue using the tools that best meet their needs, while enabling information to flow seamlessly across systems and organizational boundaries.They explore the potential to reduce administrative complexity, improve interoperability, strengthen site efficiency, and keep humans at the center of critical decisions, ultimately creating more time and capacity for what matters most: patients.
What does the future of early-stage clinical research look like?In this episode, experts from clinical operations, IRB/regulatory oversight, and technology/policy — Amy Roach (Parexel), Bert Wilkins (WCG), and Jackie Ward (Veeva) — explore the evolving landscape of early-stage clinical trials in the U.S. From regulatory modernization and global competitiveness to interoperability, participant access, and increasingly complex trial designs, the discussion centers on how the U.S. can improve speed, efficiency, and predictability while preserving safety, rigor, and quality.
AI is transforming trial monitoring from a reactive process into a proactive, risk-driven discipline. In this episode, ACRO RBQM Working Group members Cris McDavid (Parexel), Shailesh Madel (ICON), and Linda Phillips (IQVIA), come together to examine how artificial intelligence and machine learning can help identify risks and signals faster while humans maintain accountability and oversight.From accelerating the identification of Critical-to-Quality (CtQ) factors and enhancing centralized monitoring to addressing concerns around pushing humans out of the loop, the discussion highlights both the challenges and opportunities ahead. With insights on how AI is already being leveraged to increase operational efficiencies while balancing patient safety and data integrity, this episode offers a glimpse into the future of centralized monitoring. 
loading
Comments